XML 15 R5.htm IDEA: XBRL DOCUMENT v3.19.1
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
$ in Millions
Total Shareholders' Equity Attributable to Bruker Corporation
Common Stock
Treasury Stock
Additional Paid-In Capital
Retained Earnings
Accumulated Other Comprehensive Income (Loss)
Noncontrolling Interests in Consolidated Subsidiaries
Total
Balance at beginning of period at Dec. 31, 2017 $ 725.4 $ 1.7 $ (401.2) $ 155.9 $ 942.0 $ 27.0 $ 8.1 $ 733.5
Balance (in shares) at Dec. 31, 2017   155,865,977 16,009,099          
Increase (Decrease) in Stockholders' Equity                
Restricted shares terminated (in shares)   (6,553) 6,553          
Stock options exercised 2.9     2.9       2.9
Stock options exercised (in shares)   180,890            
Restricted stock units vested (in shares)   42,762            
Stock based compensation 2.5     2.5       2.5
Shares issued for acquisition (0.1)   $ (0.1)         (0.1)
Shares issued for acquisition (in shares)   (2,123) 2,123          
Treasury stock acquired (in shares)   (1,055) 1,055          
Adoption impact from new revenue standard | ASC 606 5.9       5.9   0.2 6.1
Cash dividends paid to common stockholders (6.3)       (6.3)     (6.3)
Consolidated net income 27.0       27.0   0.4 27.4
Other comprehensive income (loss) 24.2         24.2 0.1 24.3
Balance at end of period at Mar. 31, 2018 781.5 $ 1.7 $ (401.3) 161.3 968.6 51.2 8.8 790.3
Balance (in shares) at Mar. 31, 2018   156,079,898 16,018,830          
Balance at beginning of period at Dec. 31, 2018 896.6 $ 1.7 $ (401.5) 176.9 1,102.5 17.0 8.5 905.1
Balance (in shares) at Dec. 31, 2018   156,609,340 16,024,880          
Increase (Decrease) in Stockholders' Equity                
Stock options exercised 3.1     3.1       3.1
Stock options exercised (in shares)   167,177            
Restricted stock units vested (in shares)   35,072            
Stock based compensation 2.7     2.7       2.7
Shares issued for acquisition (in shares)   3,087 (3,087)          
Cash dividends paid to common stockholders (6.3)       (6.3)     (6.3)
Consolidated net income 30.8       30.8   (0.1) 30.7
Other comprehensive income (loss) (13.7)         (13.7)   (13.7)
Balance at end of period at Mar. 31, 2019 $ 913.2 $ 1.7 $ (401.5) $ 182.7 $ 1,127.0 $ 3.3 $ 8.4 $ 921.6
Balance (in shares) at Mar. 31, 2019   156,814,676 16,021,793